Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 375681, 19 pages
http://dx.doi.org/10.1155/2014/375681
Review Article

Emerging Rapid Resistance Testing Methods for Clinical Microbiology Laboratories and Their Potential Impact on Patient Management

1Fachbereich Tropenmedizin am Bernhard-Nocht-Institut, Bundeswehrkrankenhaus Hamburg, 20359 Hamburg, Germany
2Institut für Medizinische Mikrobiologie, Virologie und Hygiene, Universitätsmedizin Rostock, 18057 Rostock, Germany
3UMG-Labor, Abteilung Klinische Chemie/Zentrallabor, Universitätsmedizin Göttingen, 37075 Göttingen, Germany
4Institut für Medizinische Mikrobiologie, Universitätsmedizin Göttingen, Kreuzbergring 57, 37075 Göttingen, Germany

Received 14 July 2014; Revised 22 August 2014; Accepted 28 August 2014; Published 17 September 2014

Academic Editor: Gundlapally S. Reddy

Copyright © 2014 Hagen Frickmann et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. WHO, Antimicrobial Resistance: Global Report on Surveillance, WHO, 2014.
  2. Y.-L. Lee, Y.-S. Chen, H.-S. Toh et al., “Antimicrobial susceptibility of pathogens isolated from patients with complicated intra-abdominal infections at five medical centers in Taiwan that continuously participated in the Study for Monitoring Antimicrobial Resistance Trends (SMART) from 2006 to 2010,” International Journal of Antimicrobial Agents, vol. 40, supplement 1, pp. S29–S36, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Ghebremedhin, “Extended-spectrum of beta-lactamases (ESBL): yesterday ESBL: and today ESBL, carbapenemase-producing and multiresistant bacteria,” Deutsche Medizinische Wochenschrift, vol. 137, no. 50, pp. 2657–2662, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. D. M. Livermore, “Current epidemiology and growing resistance of Gram-negative pathogens,” Korean Journal of Internal Medicine, vol. 27, no. 2, pp. 128–142, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Nordmann, G. Cuzon, and T. Naas, “The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria,” The Lancet Infectious Diseases, vol. 9, no. 4, pp. 228–236, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. D. J. Wolter, P. M. Kurpiel, N. Woodford, M.-F. I. Palepou, R. V. Goering, and N. D. Hanson, “Phenotypic and enzymatic comparative analysis of the novel KPC variant KPC-5 and its evolutionary variants, KPC-2 and KPC-4,” Antimicrobial Agents and Chemotherapy, vol. 53, no. 2, pp. 557–562, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Endimiani, A. M. Hujer, F. Perez et al., “Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA,” The Journal of Antimicrobial Chemotherapy, vol. 63, no. 3, pp. 427–437, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Hidalgo, K. L. Hopkins, B. Gutierrez et al., “Association of the novel aminoglycoside resistance determinant RmtF with NDM carbapenemase in enterobacteriaceae isolated in India and the UK,” Journal of Antimicrobial Chemotherapy, vol. 68, no. 7, pp. 1543–1550, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. M.-H. Nicolas-chanoine, C. Gruson, S. Bialek-Davenet et al., “10-fold increase (2006–11) in the rate of healthy subjects with extended-spectrum β-lactamase-producing Escherichia coli faecal carriage in a parisian check-up centre,” The Journal of Antimicrobial Chemotherapy, vol. 68, no. 3, pp. 562–568, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Birgy, R. Cohen, C. Levy et al., “Community faecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae in french children,” BMC Infectious Diseases, vol. 12, article 315, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Tham, M. Walder, E. Melander, and I. Odenholt, “Duration of colonization with extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers' diarrhoea,” Scandinavian Journal of Infectious Diseases, vol. 44, no. 8, pp. 573–577, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Birgand, L. Armand-Lefevre, I. Lolom, E. Ruppe, A. Andremont, and J.-C. Lucet, “Duration of colonization by extended-spectrum β-lactamase-producing Enterobacteriaceae after hospital discharge,” The American Journal of Infection Control, vol. 41, no. 5, pp. 443–447, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. I. H. Löhr, S. Rettedal, O. B. Natås, U. Naseer, K. Øymar, and A. Sundsfjord, “Long-term faecal carriage in infants and intra-household transmission of CTX-M-15-producing Klebsiella pneumoniae following a nosocomial outbreak,” The Journal of Antimicrobial Chemotherapy, vol. 68, no. 5, Article ID dks502, pp. 1043–1048, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. J. L. Cottell, M. A. Webber, and L. J. V. Piddock, “Persistence of transferable extended-spectrum-β-lactamase resistance in the absence of antibiotic pressure,” Antimicrobial Agents and Chemotherapy, vol. 56, no. 9, pp. 4703–4706, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. J. Ko, H. W. Moon, M. Hur, C. M. Park, S. E. Cho, and Y. M. Yun, “Fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in Korean community and hospital settings,” Infection, vol. 41, no. 1, pp. 9–13, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. U.-O. Luvsansharav, I. Hirai, A. Nakata et al., “Prevalence of and risk factors associated with faecal carriage of CTX-M β-lactamase-producing enterobacteriaceae in rural Thai communities,” Journal of Antimicrobial Chemotherapy, vol. 67, no. 7, Article ID dks118, pp. 1769–1774, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. N. H. Wickramasinghe, L. Xu, A. Eustace, S. Shabir, T. Saluja, and P. M. Hawkey, “High community faecal carriage rates of CTX-M ESBL-producing Escherichia coli in a specific population group in Birmingham, UK,” The Journal of Antimicrobial Chemotherapy, vol. 67, no. 5, Article ID dks018, pp. 1108–1113, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. J. A. J. W. Kluytmans, I. T. M. A. Overdevest, I. Willemsen et al., “Extended-spectrum β-lactamase-producing Escherichia coli from retail chicken meat and humans: comparison of strains, plasmids, resistance genes, and virulence factors,” Clinical Infectious Diseases, vol. 56, no. 4, pp. 478–487, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Bhattacharya, “Early diagnosis of resistant pathogens: how can it improve antimicrobial treatment?” Virulence, vol. 4, no. 2, pp. 172–184, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. WHO, Global Tuberculosis Report 2013, World Health Organization, Geneva, Switzerland, 2013.
  21. E. Shmueli, R. Or, M. Y. Shapira et al., “High rate of cytomegalovirus drug resistance among patients receiving preemptive antiviral treatment after haploidentical stem cell transplantation,” Journal of Infectious Diseases, vol. 209, no. 4, pp. 557–561, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. F. Baldanti and G. Gerna, “Human cytomegalovirus resistance to antiviral drugs: diagnosis, monitoring and clinical impact,” Journal of Antimicrobial Chemotherapy, vol. 52, no. 3, pp. 324–330, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. Y.-W. Tang and C. W. Stratton, Advanced Techniques in Diagnostic Microbiology, Springer, New York, NY, USA, 2006.
  24. A. Van Belkum, G. Durand, M. Peyret et al., “Rapid clinical bacteriology and its future impact,” Annals of Laboratory Medicine, vol. 33, no. 1, pp. 14–27, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. G. M. Trenholme, R. L. Kaplan, P. H. Karakusis et al., “Clinical impact of rapid identification and susceptibility testing of bacterial blood culture isolates,” Journal of Clinical Microbiology, vol. 27, no. 6, pp. 1342–1345, 1989. View at Google Scholar · View at Scopus
  26. R. Laxminarayan, A. Duse, C. Wattal et al., “Antibiotic resistance-the need for global solutions,” The Lancet Infectious Diseases, vol. 13, no. 12, pp. 1057–1098, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Doron and L. E. Davidson, “Antimicrobial stewardship,” Mayo Clinic Proceedings, vol. 86, no. 11, pp. 1113–1123, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. M. V. Ramirez, K. C. Cowart, P. J. Campbell et al., “Rapid detection of multidrug-resistant Mycobacterium tuberculosis by use of real-time PCR and high-resolution melt analysis,” Journal of Clinical Microbiology, vol. 48, no. 11, pp. 4003–4009, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. T. C. Dingle and S. M. Butler-Wu, “MALDI-TOF mass spectrometry for microorganism identification,” Clinics in Laboratory Medicine, vol. 33, no. 3, pp. 589–609, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Weist, A.-K. Cimbal, C. Lecke, G. Kampf, H. Rüden, and R.-P. Vonberg, “Evaluation of six agglutination tests for Staphylococcus aureus identification depending upon local prevalence of meticillin-resistant S. aureus (MRSA),” Journal of Medical Microbiology, vol. 55, no. 3, pp. 283–290, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. P. D. de Matos, R. P. Schuenck, F. S. Cavalcante, R. M. Caboclo, and K. R. N. dos Santos, “Accuracy of phenotypic methicillin susceptibility methods in the detection of Staphylococcus aureus isolates carrying different SCCmec types,” Memorias do Instituto Oswaldo Cruz, vol. 105, no. 7, pp. 931–934, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. Q. Qian, L. Venkataraman, J. E. Kirby, H. S. Gold, and T. Yamazumi, “Direct detection of methicillin resistance in Staphylococcus aureus in blood culture broth by use of a penicillin binding protein 2a latex agglutination test,” Journal of Clinical Microbiology, vol. 48, no. 4, pp. 1420–1421, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Kipp, K. Becker, G. Peters, and C. Von Eiff, “Evaluation of different methods to detect methicillin resistance in small-colony variants of Staphylococcus aureus,” Journal of Clinical Microbiology, vol. 42, no. 3, pp. 1277–1279, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. G. K. Paterson, F. J. E. Morgan, E. M. Harrison et al., “Prevalence and properties of mecc methicillin-resistant Staphylococcus aureus (mrsa) in bovine bulk tank milk in great britain,” Journal of Antimicrobial Chemotherapy, vol. 69, no. 3, Article ID dkt417, pp. 598–602, 2014. View at Publisher · View at Google Scholar · View at Scopus
  35. K. C. Chapin and M. C. Musgnug, “Evaluation of penicillin binding protein 2a latex agglutination assay for identification of methicillin-resistant Staphylococcus aureus directly from blood cultures,” Journal of Clinical Microbiology, vol. 42, no. 3, pp. 1283–1284, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. N. Woodford and A. Sundsfjord, “Molecular detection of antibiotic resistance: when and where?” Journal of Antimicrobial Chemotherapy, vol. 56, no. 2, pp. 259–261, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. P.-E. Fournier, M. Drancourt, P. Colson, J.-M. Rolain, B. L. Scola, and D. Raoult, “Modern clinical microbiology: new challenges and solutions,” Nature Reviews Microbiology, vol. 11, no. 8, pp. 574–585, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. M. J. Espy, J. R. Uhl, L. M. Sloan et al., “Real-time PCR in clinical microbiology: applications for routine laboratory testing,” Clinical Microbiology Reviews, vol. 19, pp. 165–256, 2006. View at Publisher · View at Google Scholar
  39. M. Maurin, “Real-time PCR as a diagnostic tool for bacterial diseases,” Expert Review of Molecular Diagnostics, vol. 12, no. 7, pp. 731–754, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. D. C. T. Ong, T.-H. Koh, N. Syahidah, P. Krishnan, and T. Y. Tan, “Rapid detection of the blaNDM-1 gene by real-time PCR,” Journal of Antimicrobial Chemotherapy, vol. 66, no. 7, pp. 1647–1649, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. S. A. Cunningham, T. Noorie, D. Meunier, N. Woodford, and R. Patel, “Rapid and simultaneous detection of genes encoding Klebsiella pneumoniae carbapenemase (blaKPC) and New Delhi metallo-beta-lactamase (blaNDM) in Gram-negative bacilli,” Journal of Clinical Microbiology, vol. 51, pp. 1269–1271, 2013. View at Google Scholar
  42. F. Zheng, J. Sun, C. Cheng, and Y. Rui, “The establishment of a duplex real-time PCR assay for rapid and simultaneous detection of blaNDM and blaKPC genes in bacteria,” Annals of Clinical Microbiology and Antimicrobials, vol. 12, no. 1, article 30, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. L. Huang, X. Hu, M. Zhou et al., “Rapid detection of new delhi metallo-β-lactamase gene and variants coding for carbapenemases with different activities by use of a PCR-based in vitro protein expression method,” Journal of Clinical Microbiology, vol. 52, no. 6, pp. 1947–1953, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. R. Nijhuis, Ø. Samuelsen, P. Savelkoul, and A. van Zwet, “Evaluation of a new real-time PCR assay (Check-Direct CPE) for rapid detection of KPC, OXA-48, VIM, and NDM carbapenemases using spiked rectal swabs,” Diagnostic Microbiology and Infectious Disease, vol. 77, no. 4, pp. 316–320, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. A. van der Zee, L. Roorda, G. Bosman, and et al, “Multi-centre evaluation of real-time multiplex PCR for detection of carbapenemase genes OXA-48, VIM, IMP, NDM and KPC,” BMC Infectious Diseases, vol. 14, no. 1, article 27, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. C. Cheng, F. Zheng, and Y. Rui, “Rapid detection of blaNDM, blaKPC, blaIMP, and blaVIM carbapenemase genes in bacteria by loop-mediated isothermal amplification,” Microbial Drug Resistance, 2014. View at Publisher · View at Google Scholar
  47. U. S. W. Reischl, T. Holzmann, M. Ehrenschwender et al., “Bakterien- und Pilzgenom-Nachweis PCR/NAT: Auswertung des Ringversuchs November 2013 von INSTAND e.V. zur externen Qualitätskontrolle molekularbiologischer Nachweisverfahren in der bakteriologischen Diagnostik,” Der Mikrobiologe, vol. 24, pp. 37–56, 2014. View at Google Scholar
  48. M. Al-Zarouni, A. Senok, N. Al-Zarooni, F. Al-Nassay, and D. Panigrahi, “Extended-spectrum β-lactamase-producing enterobacteriaceae: in vitro susceptibility to fosfomycin, nitrofurantoin and tigecycline,” Medical Principles and Practice, vol. 21, no. 6, pp. 543–547, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Kaase, F. Szabados, L. Wassill, and S. G. Gatermann, “Detection of carbapenemases in Enterobacteriaceae by a commercial multiplex PCR,” Journal of Clinical Microbiology, vol. 50, no. 9, pp. 3115–3118, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Avlami, S. Bekris, G. Ganteris et al., “Detection of metallo-β-lactamase genes in clinical specimens by a commercial multiplex PCR system,” Journal of Microbiological Methods, vol. 83, no. 2, pp. 185–187, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. N. P. Pai, C. Vadnais, C. Denkinger, N. Engel, and M. Pai, “Point-of-care testing for infectious diseases: diversity, complexity, and barriers in low- and middle-income countries,” PLoS Medicine, vol. 9, no. 9, Article ID e1001306, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. C. C. Boehme, M. P. Nicol, P. Nabeta et al., “Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study,” The Lancet, vol. 377, no. 9776, pp. 1495–1505, 2011. View at Publisher · View at Google Scholar · View at Scopus
  53. B. Strommenger, C. Kettlitz, G. Werner, and W. Witte, “Multiplex PCR assay for simultaneous detection of nine clinically relevant antibiotic resistance genes in Staphylococcus aureus,” Journal of Clinical Microbiology, vol. 41, no. 9, pp. 4089–4094, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. W. Jamal, E. Al Roomi, L. R. AbdulAziz, and V. O. Rotimi, “Evaluation of Curetis Unyvero, a multiplex PCR-based testing system, for rapid detection of bacteria and antibiotic resistance and impact of the assay on management of severe nosocomial pneumonia,” Journal of Clinical Microbiology, vol. 52, pp. 2487–2492, 2014. View at Publisher · View at Google Scholar
  55. Z. Zhang, L. Li, F. Luo et al., “Rapid and accurate detection of RMP- and INH-resistant Mycobacterium tuberculosis in spinal tuberculosis specimens by CapitalBio DNA microarray: a prospective validation study,” BMC Infectious Diseases, vol. 12, article 303, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. Y. Guo, Y. Zhou, C. Wang et al., “Rapid, accurate determination of multidrug resistance in M. tuberculosis isolates and sputum using a biochip system,” International Journal of Tuberculosis and Lung Disease, vol. 13, no. 7, pp. 914–920, 2009. View at Google Scholar · View at Scopus
  57. T. Naas, G. Cuzon, H. Truong, S. Bernabeu, and P. Nordmann, “Evaluation of a DNA microarray, the check-points ESBL/KPC array, for rapid detection of TEM, SHV, and CTX-M extended-spectrum β-lactamases and KPC carbapenemases,” Antimicrobial Agents and Chemotherapy, vol. 54, no. 8, pp. 3086–3092, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. I. Willemsen, I. Overdevest, N. Al Naiemi et al., “New Diagnostic microarray (check-KPC ESBL) for detection and identification of extended-spectrum beta-lactamases in highly resistant Enterobacteriaceae,” Journal of Clinical Microbiology, vol. 49, no. 8, pp. 2985–2987, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. A. Endimiani, K. M. Hujer, A. M. Hujer et al., “Are we ready for novel detection methods to treat respiratory pathogens in hospital-acquired pneumonia?” Clinical Infectious Diseases, vol. 52, supplement 4, pp. S373–S383, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. J. C. Stuart, G. Voets, J. Scharringa, A. C. Fluit, and M. A. Leverstein-Van Hall, “Detection of carbapenemase-producing Enterobacteriaceae with a commercial DNA microarray,” Journal of Medical Microbiology, vol. 61, no. 6, pp. 809–812, 2012. View at Publisher · View at Google Scholar · View at Scopus
  61. V. Mikhailovich, D. Gryadunov, A. Kolchinsky, A. A. Makarov, and A. Zasedatelev, “DNA microarrays in the clinic: Infectious diseases,” BioEssays, vol. 30, no. 7, pp. 673–682, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. G. Zhang, F. Cai, Z. Zhou et al., “Simultaneous detection of major drug resistance mutations in the protease and reverse transcriptase genes for HIV-1 subtype C by use of a multiplex allele-specific assay,” Journal of Clinical Microbiology, vol. 51, no. 11, pp. 3666–3674, 2013. View at Publisher · View at Google Scholar · View at Scopus
  63. P. Masimba, J. Gare, T. Klimkait, M. Tanner, and I. Felger, “Development of a simple microarray for genotyping HIV-1 drug resistance mutations in the reverse transcriptase gene in rural Tanzania,” Tropical Medicine and International Health, vol. 19, no. 6, pp. 664–671, 2014. View at Publisher · View at Google Scholar · View at Scopus
  64. Y. Linger, A. Kukhtin, J. Golova et al., “Simplified microarray system for simultaneously detecting rifampin, isoniazid, ethambutol, and streptomycin resistance markers in Mycobacterium tuberculosis,” Journal of Clinical Microbiology, vol. 52, no. 6, pp. 2100–2107, 2014. View at Publisher · View at Google Scholar · View at Scopus
  65. R. Moure, M. Español, G. Tudó et al., “Characterization of the embB gene in Mycobacterium tuberculosis isolates from barcelona and rapid detection of main mutations related to ethambutol resistance using a low-density DNA array,” Journal of Antimicrobial Chemotherapy, vol. 69, no. 4, pp. 947–954, 2014. View at Publisher · View at Google Scholar · View at Scopus
  66. A. Chatterjee, D. Saranath, P. Bhatter, and N. Mistry, “Global transcriptional profiling of longitudinal clinical isolates of Mycobacterium tuberculosis exhibiting rapid accumulation of drug resistance,” PLoS ONE, vol. 8, no. 1, Article ID e54717, 2013. View at Publisher · View at Google Scholar · View at Scopus
  67. M. B. Miller and Y.-W. Tang, “Basic concepts of microarrays and potential applications in clinical microbiology,” Clinical Microbiology Reviews, vol. 22, no. 4, pp. 611–633, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. A. Afshari, J. Schrenzel, M. Ieven, and S. Harbarth, “Bench-to-bedside review: rapid molecular diagnostics for bloodstream infection—a new frontier?” Critical Care, vol. 16, no. 3, article 222, 2012. View at Publisher · View at Google Scholar · View at Scopus
  69. R. P. Podzorski, H. Li, J. Han, and Y.-W. Tang, “MVPlex assay for direct detection of methicillin-resistant Staphylococcus aureus in naris and other swab specimens,” Journal of Clinical Microbiology, vol. 46, no. 9, pp. 3107–3109, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. Y.-W. Tang, A. Kilic, Q. Yang et al., “StaphPlex system for rapid and simultaneous identification of antibiotic resistance determinants and Panton-Valentine leukocidin detection of staphylococci from positive blood cultures,” Journal of Clinical Microbiology, vol. 45, no. 6, pp. 1867–1873, 2007. View at Publisher · View at Google Scholar · View at Scopus
  71. P. Roumagnac, F.-X. Weill, C. Dolecek et al., “Evolutionary history of Salmonella typhi,” Science, vol. 314, no. 5803, pp. 1301–1304, 2006. View at Publisher · View at Google Scholar · View at Scopus
  72. T. W. Jesse, M. D. Englen, L. G. Pittenger-Alley, and P. J. Fedorka-Cray, “Two distinct mutations in gyrA lead to ciprofloxacin and nalidixic acid resistance in Campylobacter coli and Campylobacter jejuni isolated from chickens and beef cattle,” Journal of Applied Microbiology, vol. 100, no. 4, pp. 682–688, 2006. View at Publisher · View at Google Scholar · View at Scopus
  73. C. F. Taylor and G. R. Taylor, “Current and emerging techniques for diagnostic mutation detection: an overview of methods for mutation detection,” Methods in Molecular Medicine, vol. 92, pp. 9–44, 2004. View at Google Scholar · View at Scopus
  74. S. A. Dunbar, “Applications of Luminex® xMAP technology for rapid, high-throughput multiplexed nucleic acid detection,” Clinica Chimica Acta, vol. 363, no. 1-2, pp. 71–82, 2006. View at Publisher · View at Google Scholar · View at Scopus
  75. Y. Song, P. Roumagnac, F.-X. Weill et al., “A multiplex single nucleotide polymorphism typing assay for detecting mutations that result in decreased fluoroquinolone susceptibility in Salmonella enterica serovars Typhi and Paratyphi A,” The Journal of Antimicrobial Chemotherapy, vol. 65, no. 8, Article ID dkq175, pp. 1631–1641, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. L. Barco, A. A. Lettini, M. C. D. Pozza, E. Ramon, M. Fasolato, and A. Ricci, “Fluoroquinolone resistance detection in campylobacter coli and campylobacter jejuni by luminex xMAP technology,” Foodborne Pathogens and Disease, vol. 7, no. 9, pp. 1039–1045, 2010. View at Publisher · View at Google Scholar · View at Scopus
  77. N. J. Loman, R. V. Misra, T. J. Dallman et al., “Performance comparison of benchtop high-throughput sequencing platforms,” Nature Biotechnology, vol. 30, no. 5, pp. 434–439, 2012. View at Publisher · View at Google Scholar · View at Scopus
  78. A. Mellmann, D. Harmsen, C. A. Cummings et al., “Prospective genomic characterization of the german enterohemorrhagic Escherichia coli O104:H4 outbreak by rapid next generation sequencing technology,” PLoS ONE, vol. 6, no. 7, Article ID e22751, 2011. View at Publisher · View at Google Scholar · View at Scopus
  79. T. A. Kohl, R. Diel, D. Harmsen et al., “Whole-genome-based Mycobacterium tuberculosis surveillance: a standardized, portable, and expandable approach,” Journal of Clinical Microbiology, vol. 52, pp. 2479–2486, 2014. View at Google Scholar
  80. D. M. Livermore and J. Wain, “Revolutionising bacteriology to improve treatment outcomes and antibiotic stewardship,” Infection & Chemotherapy, vol. 45, no. 1, pp. 1–10, 2013. View at Publisher · View at Google Scholar · View at Scopus
  81. A. Lupo, K. M. Papp-Wallace, P. Sendi, R. A. Bonomo, and A. Endimiani, “Non-phenotypic tests to detect and characterize antibiotic resistance mechanisms in Enterobacteriaceae,” Diagnostic Microbiology and Infectious Disease, vol. 77, no. 3, pp. 179–194, 2013. View at Publisher · View at Google Scholar · View at Scopus
  82. L. T. Daum, G. W. Fischer, J. Sromek et al., “Characterization of multi-drug resistant Mycobacterium tuberculosis from immigrants residing in the USA using Ion Torrent full-gene sequencing,” Epidemiology and Infection, vol. 142, no. 6, pp. 1328–1333, 2014. View at Publisher · View at Google Scholar · View at Scopus
  83. E. N. Ilina, E. A. Shitikov, L. N. Ikryannikova et al., “Comparative genomic analysis of Mycobacterium tuberculosis drug resistant strains from Russia,” PLoS ONE, vol. 8, no. 2, Article ID e56577, 2013. View at Publisher · View at Google Scholar · View at Scopus
  84. L. T. Daum, J. D. Rodriguez, S. A. Worthy et al., “Next-generation ion torrent sequencing of drug resistance mutations in Mycobacterium tuberculosis strains,” Journal of Clinical Microbiology, vol. 50, no. 12, pp. 3831–3837, 2012. View at Publisher · View at Google Scholar · View at Scopus
  85. S. Das, T. Roychowdhury, P. Kumar et al., “Genetic heterogeneity revealed by sequence analysis of Mycobacterium tuberculosis isolates from extra-pulmonary tuberculosis patients,” BMC Genomics, vol. 14, no. 1, article 404, 2013. View at Publisher · View at Google Scholar · View at Scopus
  86. J. Wang, R. Stephan, K. Power, Q. Yan, H. Hächler, and S. Fanning, “Nucleotide sequences of 16 transmissible plasmids identified in nine multidrug-resistant Escherichia coli isolates expressing an ESBL phenotype isolated from food-producing animals and healthy humans,” The Journal of Antimicrobial Chemotherapy, 2014. View at Publisher · View at Google Scholar
  87. A. Brolund, O. Franzén, Ö. Melefors, K. Tegmark-Wisell, and L. Sandegren, “Plasmidome-analysis of ESBL-producing escherichia coli using conventional typing and high-throughput sequencing,” PLoS ONE, vol. 8, no. 6, Article ID e65793, 2013. View at Publisher · View at Google Scholar · View at Scopus
  88. J. Veenemans, I. T. Overdevest, E. Snelders et al., “Next generation Sequencing for typing and detection of resistance genes: performance of a new commercial method during an outbreak of ESBL-producing Escherichia coli,” Journal of Clinical Microbiology, vol. 52, no. 7, pp. 2454–2460, 2014. View at Google Scholar
  89. N. L. Sherry, J. L. Porter, T. Seemann, A. Watkins, T. P. Stinear, and B. P. Howden, “Outbreak investigation using high-throughput genome sequencing within a diagnostic microbiology laboratory,” Journal of Clinical Microbiology, vol. 51, no. 5, pp. 1396–1401, 2013. View at Publisher · View at Google Scholar · View at Scopus
  90. W. M. Dunne, L. F. Westblade, and B. Ford, “Next-generation and whole-genome sequencing in the diagnostic clinical microbiology laboratory,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 31, no. 8, pp. 1719–1726, 2012. View at Publisher · View at Google Scholar · View at Scopus
  91. A. Moter and U. B. Göbel, “Fluorescence in situ hybridization (FISH) for direct visualization of microorganisms,” Journal of Microbiological Methods, vol. 41, no. 2, pp. 85–112, 2000. View at Publisher · View at Google Scholar · View at Scopus
  92. H. Stender, “PNA FISH: an intelligent stain for rapid diagnosis of infectious diseases,” Expert Review of Molecular Diagnostics, vol. 3, no. 5, pp. 649–655, 2003. View at Publisher · View at Google Scholar · View at Scopus
  93. H. Rüssmann, V. A. J. Kempf, S. Koletzko, J. Heesemann, and I. B. Autenrieth, “Comparison of fluorescent in situ hybridization and conventional culturing for detection of Helicobacter pylori in gastric biopsy specimens,” Journal of Clinical Microbiology, vol. 39, no. 1, pp. 304–308, 2001. View at Publisher · View at Google Scholar · View at Scopus
  94. Ö. Yilmaz and E. Demiray, “Clinical role and importance of fluorescence in situ hybridization method in diagnosis of H pylori infection and determination of clarithromycin resistance in H pylori eradication therapy,” World Journal of Gastroenterology, vol. 13, no. 5, pp. 671–675, 2007. View at Publisher · View at Google Scholar · View at Scopus
  95. H. Rüssmann, K. Adler, R. Haas, B. Gebert, S. Koletzko, and J. Heesemann, “Rapid and accurate determination of genotypic clarithromycin resistance in cultured Helicobacter pylori by fluorescent in situ hybridization,” Journal of Clinical Microbiology, vol. 39, no. 11, pp. 4142–4144, 2001. View at Publisher · View at Google Scholar · View at Scopus
  96. H. Rüssmann, A. Feydt-Schmidt, K. Adler, D. Aust, A. Fischer, and S. Koletzko, “Detection of Helicobacter pylori in paraffin-embedded and in shock-frozen gastric biopsy samples by fluorescent in situ hybridization,” Journal of Clinical Microbiology, vol. 41, no. 2, pp. 813–815, 2003. View at Publisher · View at Google Scholar · View at Scopus
  97. A. Feydt-Schmidt, H. Rüssmann, N. Lehn et al., “Fluorescence in situ hybridization vs. epsilometer test for detection of clarithromycin-susceptible and clarithromycin-resistant Helicobacter pylori strains in gastric biopsies from children,” Alimentary Pharmacology and Therapeutics, vol. 16, no. 12, pp. 2073–2079, 2002. View at Publisher · View at Google Scholar · View at Scopus
  98. S. Jüttner, M. Vieth, S. Miehlke et al., “Reliable detection of macrolide-resistant Helicobacter pylori via fluorescence in situ hybridization in formalin-fixed tissue,” Modern Pathology, vol. 17, no. 6, pp. 684–689, 2004. View at Publisher · View at Google Scholar · View at Scopus
  99. E. Caristo, A. Parola, A. Rapa et al., “Clarithromycin resistance of Helicobacter pylori strains isolated from children' gastric antrum and fundus as assessed by fluorescent in-situ hybridization and culture on four-sector agar plates,” Helicobacter, vol. 13, no. 6, pp. 557–563, 2008. View at Publisher · View at Google Scholar · View at Scopus
  100. A. E. Vega, T. Alarcón, D. Domingo, and M. López-Brea, “Detection of clarithromycin-resistant Helicobacter pylori in frozen gastric biopsies from pediatric patients by a commercially available fluorescent in situ hybridization,” Diagnostic Microbiology and Infectious Disease, vol. 59, no. 4, pp. 421–423, 2007. View at Publisher · View at Google Scholar · View at Scopus
  101. Ö. Yilmaz, E. Demiray, S. Tümer et al., “Detection of Helicobacter pylori and determination of clarithromycin susceptibility using formalin-fixed, paraffin-embedded gastric biopsy specimens by fluorescence in situ hybridization,” Helicobacter, vol. 12, no. 2, pp. 136–141, 2007. View at Publisher · View at Google Scholar · View at Scopus
  102. L. Cerqueira, R. M. Fernandes, R. M. Ferreira et al., “Validation of a fluorescence in situ hybridization method using peptide nucleic acid probes for detection of Helicobacter pylori clarithromycin resistance in gastric biopsy specimens,” Journal of Clinical Microbiology, vol. 51, no. 6, pp. 1887–1893, 2013. View at Publisher · View at Google Scholar · View at Scopus
  103. M. Haas, A. Essig, E. Bartelt, and S. Poppert, “Detection of resistance to macrolides in thermotolerant Campylobacter species by fluorescence in situ hybridization,” Journal of Clinical Microbiology, vol. 46, no. 11, pp. 3842–3844, 2008. View at Publisher · View at Google Scholar · View at Scopus
  104. G. Werner, M. Bartel, N. Wellinghausen et al., “Detection of mutations conferring resistance to linezolid in Enterococcus spp. by fluorescence in situ hybridization,” Journal of Clinical Microbiology, vol. 45, no. 10, pp. 3421–3423, 2007. View at Publisher · View at Google Scholar · View at Scopus
  105. S. Palasubramaniam, S. Muniandy, and P. Navaratnam, “Rapid detection of ESBL-producing Klebsiella pneumoniae in blood cultures by fluorescent in-situ hybridization,” Journal of Microbiological Methods, vol. 72, no. 1, pp. 107–109, 2008. View at Publisher · View at Google Scholar · View at Scopus
  106. M. Wagner and S. Haider, “New trends in fluorescence in situ hybridization for identification and functional analyses of microbes,” Current Opinion in Biotechnology, vol. 23, no. 1, pp. 96–102, 2012. View at Publisher · View at Google Scholar · View at Scopus
  107. I. Smolina, N. S. Miller, and M. D. Frank-Kamenetskii, “PNA-based microbial pathogen identification and resistance marker detection: An accurate, isothermal rapid assay based on genome-specific features,” Artificial DNA: PNA and XNA, vol. 1, no. 2, pp. 76–82, 2010. View at Publisher · View at Google Scholar · View at Scopus
  108. A. Swidsinski, “Standards for bacterial identification by fluorescence in situ hybridization within eukaryotic tissue using ribosomal rRNA-based probes,” Inflammatory Bowel Diseases, vol. 12, no. 8, pp. 824–826, 2006. View at Publisher · View at Google Scholar · View at Scopus
  109. Q. Shao, Y. Zheng, X. Dong, K. Tang, X. Yan, and B. Xing, “A covalent reporter of β-lactamase activity for fluorescent imaging and rapid screening of antibiotic-resistant bacteria,” Chemistry, vol. 19, no. 33, pp. 10903–10910, 2013. View at Publisher · View at Google Scholar · View at Scopus
  110. P. Seng, M. Drancourt, F. Gouriet et al., “Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry,” Clinical Infectious Diseases, vol. 49, no. 4, pp. 543–551, 2009. View at Publisher · View at Google Scholar · View at Scopus
  111. O. Bader, M. Weig, L. Taverne-Ghadwal, R. Lugert, U. Groß, and M. Kuhns, “Improved clinical laboratory identification of human pathogenic yeasts by matrix-assisted laser desorption ionization time-of-flight mass spectrometry,” Clinical Microbiology and Infection, vol. 17, no. 9, pp. 1359–1365, 2011. View at Publisher · View at Google Scholar · View at Scopus
  112. A. Wieser, L. Schneider, J. Jung, and S. Schubert, “MALDI-TOF MS in microbiological diagnostics-identification of microorganisms and beyond (mini review),” Applied Microbiology and Biotechnology, vol. 93, no. 3, pp. 965–974, 2012. View at Publisher · View at Google Scholar · View at Scopus
  113. O. Bader, “MALDI-TOF-MS-based species identification and typing approaches in medical mycology,” Proteomics, vol. 13, no. 5, pp. 788–799, 2013. View at Publisher · View at Google Scholar · View at Scopus
  114. M. L. DeMarco and B. A. Ford, “Beyond identification: emerging and future uses for maldi-tof mass spectrometry in the clinical microbiology laboratory,” Clinics in Laboratory Medicine, vol. 33, no. 3, pp. 611–628, 2013. View at Publisher · View at Google Scholar · View at Scopus
  115. E. Shitikov, E. Ilina, L. Chernousova et al., “Mass spectrometry based methods for the discrimination and typing of mycobacteria,” Infection, Genetics and Evolution, vol. 12, no. 4, pp. 838–845, 2012. View at Publisher · View at Google Scholar · View at Scopus
  116. M. Reil, M. Erhard, E. J. Kuijper et al., “Recognition of Clostridium difficile PCR-ribotypes 001, 027 and 126/078 using an extended MALDI-TOF MS system,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 30, no. 11, pp. 1431–1436, 2011. View at Publisher · View at Google Scholar · View at Scopus
  117. A. Novais, C. Sousa, J. de Dios Caballero et al., “MALDI-TOF mass spectrometry as a tool for the discrimination of high-risk Escherichia coli clones from phylogenetic groups B2 (ST131) and D (ST69, ST405, ST393),” European Journal of Clinical Microbiology and Infectious Diseases, pp. 1–9, 2014. View at Publisher · View at Google Scholar · View at Scopus
  118. Y. Matsumura, M. Yamamoto, M. Nagao et al., “Detection of extended-spectrum-β-lactamase-producing escherichia coli ST131 and ST405 clonal groups by matrix-assisted laser desorption ionization-time of flight mass spectrometry,” Journal of Clinical Microbiology, vol. 52, no. 4, pp. 1034–1040, 2014. View at Publisher · View at Google Scholar · View at Scopus
  119. I. Wybo, A. de Bel, O. Soetens et al., “Differentiation of cfiA-negative and cfiA-positive Bacteroides fragilis isolates by matrix-assisted laser desorption ionization-time of flight mass spectrometry,” Journal of Clinical Microbiology, vol. 49, no. 5, pp. 1961–1964, 2011. View at Publisher · View at Google Scholar · View at Scopus
  120. E. Nagy, S. Becker, J. Sóki, E. Urbán, and M. Kostrzewa, “Differentiation of division I (cfiA-negative) and division II (cfiA-positive) Bacteroides fragilis strains by matrix-assisted laser desorption/ionization time of-flight mass spectrometry,” Journal of Medical Microbiology, vol. 60, no. 11, pp. 1584–1590, 2011. View at Publisher · View at Google Scholar · View at Scopus
  121. P. M. Griffin, G. R. Price, J. M. Schooneveldt et al., “Use of matrix-assisted laser desorption ionization-time of flight mass spectrometry to identify vancomycin-resistant enterococci and investigate the epidemiology of an outbreak,” Journal of Clinical Microbiology, vol. 50, no. 9, pp. 2918–2931, 2012. View at Publisher · View at Google Scholar · View at Scopus
  122. C. Marinach, A. Alanio, M. Palous et al., “MALDI-TOF MS-based drug susceptibility testing of pathogens: the example of Candida albicans and fluconazole,” Proteomics, vol. 9, no. 20, pp. 4627–4631, 2009. View at Publisher · View at Google Scholar · View at Scopus
  123. E. de Carolis, A. Vella, A. R. Florio et al., “Use of matrix-assisted laser desorption ionization-time of flight mass spectrometry for caspofungin susceptibility testing of Candida and Aspergillus species,” Journal of Clinical Microbiology, vol. 50, no. 7, pp. 2479–2483, 2012. View at Publisher · View at Google Scholar · View at Scopus
  124. A. Vella, E. de Carolis, L. Vaccaro et al., “Rapid antifungal susceptibility testing by matrix-assisted laser desorption ionization-time of flight mass spectrometry analysis,” Journal of Clinical Microbiology, vol. 51, no. 9, pp. 2964–2969, 2013. View at Publisher · View at Google Scholar · View at Scopus
  125. M. Kostrzewa, K. Sparbier, T. Maier, and S. Schubert, “MALDI-TOF MS: an upcoming tool for rapid detection of antibiotic resistance in microorganisms,” Proteomics: Clinical Applications, vol. 7, no. 11-12, pp. 767–778, 2013. View at Publisher · View at Google Scholar · View at Scopus
  126. J. S. Jung, T. Eberl, K. Sparbier et al., “Rapid detection of antibiotic resistance based on mass spectrometry and stable isotopes,” European Journal of Clinical Microbiology & Infectious Diseases, vol. 33, pp. 949–955, 2013. View at Publisher · View at Google Scholar · View at Scopus
  127. J. Hrabák, R. Walková, V. Študentová, E. Chudáčková, and T. Bergerová, “Carbapenemase activity detection by matrix-assisted laser desorption ionization-time of flight mass spectrometry,” Journal of Clinical Microbiology, vol. 49, no. 9, pp. 3222–3227, 2011. View at Publisher · View at Google Scholar · View at Scopus
  128. I. Burckhardt and S. Zimmermann, “Using matrix-assisted laser desorption ionization-time of flight mass spectrometry to detect carbapenem resistance within 1 to 2.5 hours,” Journal of Clinical Microbiology, vol. 49, no. 9, pp. 3321–3324, 2011. View at Publisher · View at Google Scholar · View at Scopus
  129. G. P. Hooff, J. J. A. van Kampen, R. J. W. Meesters, A. van Belkum, W. H. F. Goessens, and T. M. Luider, “Characterization of β-lactamase enzyme activity in bacterial lysates using MALDI-mass spectrometry,” Journal of Proteome Research, vol. 11, no. 1, pp. 79–84, 2012. View at Publisher · View at Google Scholar · View at Scopus
  130. J. Hrabák, V. Študentová, R. Walková et al., “Detection of NDM-1, VIM-1, KPC, OXA-48, and OXA-162 carbapenemases by matrix-assisted laser desorption ionization-time of flight mass spectrometry,” Journal of Clinical Microbiology, vol. 50, no. 7, pp. 2441–2443, 2012. View at Publisher · View at Google Scholar · View at Scopus
  131. K. Sparbier, S. Schubert, U. Weller, C. Boogen, and M. Kostrzewa, “Matrix-assisted laser desorption ionization-time of flight mass spectrometry-based functional assay for rapid detection of resistance against β-lactam antibiotics,” Journal of Clinical Microbiology, vol. 50, no. 3, pp. 927–937, 2012. View at Publisher · View at Google Scholar · View at Scopus
  132. A. Endimiani, G. Patel, K. M. Hujer et al., “In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistin,” Antimicrobial Agents and Chemotherapy, vol. 54, no. 1, pp. 526–529, 2010. View at Publisher · View at Google Scholar · View at Scopus
  133. C. A. Wise, M. Paris, B. Morar, W. Wang, L. Kalaydjieva, and A. H. Bittles, “A standard protocol for single nucleotide primer extension in the human genome using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry,” Rapid Communications in Mass Spectrometry, vol. 17, no. 11, pp. 1195–1202, 2003. View at Publisher · View at Google Scholar · View at Scopus
  134. S. Zürcher, C. Mooser, A. U. Lüthi et al., “Sensitive and rapid detection of ganciclovir resistance by PCR based MALDI-TOF analysis,” Journal of Clinical Virology, vol. 54, no. 4, pp. 359–363, 2012. View at Publisher · View at Google Scholar · View at Scopus
  135. C. Honisch, Y. Chen, C. Mortimer et al., “Automated comparative sequence analysis by base-specific cleavage and mass spectrometry for nucleic acid-based microbial typing,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 25, pp. 10649–10654, 2007. View at Publisher · View at Google Scholar · View at Scopus
  136. C. C. Posthuma, M. T. van der Beek, C. S. van der Blij-de Brouwer et al., “Mass spectrometry-based comparative sequencing to detect ganciclovir resistance in the UL97 gene of human cytomegalovirus,” Journal of Clinical Virology, vol. 51, no. 1, pp. 25–30, 2011. View at Publisher · View at Google Scholar · View at Scopus
  137. M.-F. Lartigue, “Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for bacterial strain characterization,” Infection, Genetics and Evolution, vol. 13, no. 1, pp. 230–235, 2013. View at Publisher · View at Google Scholar · View at Scopus
  138. P. R. Murray, “Matrix-assisted laser desorption ionization time-of-flight mass spectrometry: usefulness for taxonomy and epidemiology,” Clinical Microbiology and Infection, vol. 16, no. 11, pp. 1626–1630, 2010. View at Publisher · View at Google Scholar · View at Scopus
  139. M. Kuhns, A. E. Zautner, W. Rabsch et al., “Rapid discrimination of Salmonella enterica serovar typhi from other serovars by MALDI-TOF mass spectrometry,” PLoS ONE, vol. 7, no. 6, Article ID e40004, 2012. View at Publisher · View at Google Scholar · View at Scopus
  140. A. E. Zautner, W. O. Masanta, A. M. Tareen et al., “Discrimination of multilocus sequence typing-based Campylobacter jejuni subgroups by MALDI-TOF mass spectrometry,” BMC Microbiology, vol. 13, article 247, 2013. View at Publisher · View at Google Scholar · View at Scopus
  141. K. Teramoto, W. Kitagawa, H. Sato, M. Torimura, T. Tamura, and H. Tao, “Phylogenetic analysis of Rhodococcus erythropolis based on the variation of ribosomal proteins as observed by matrix-assisted laser desorption ionization-mass spectrometry without using genome information,” Journal of Bioscience and Bioengineering, vol. 108, no. 4, pp. 348–353, 2009. View at Publisher · View at Google Scholar · View at Scopus
  142. K. Teramoto, H. Sato, L. Sun et al., “Phylogenetic classification of Pseudomonas putida strains by MALDI-MS using ribosomal subunit proteins as biomarkers,” Analytical Chemistry, vol. 79, no. 22, pp. 8712–8719, 2007. View at Publisher · View at Google Scholar · View at Scopus
  143. S. Suarez, A. Ferroni, A. Lotz et al., “Ribosomal proteins as biomarkers for bacterial identification by mass spectrometry in the clinical microbiology laboratory,” Journal of Microbiological Methods, vol. 94, no. 3, pp. 390–396, 2013. View at Publisher · View at Google Scholar · View at Scopus
  144. V. Edwards-Jones, M. A. Claydon, D. J. Evason, J. Walker, A. J. Fox, and D. B. Gordon, “Rapid discrimination between methicillin-sensitive and methicillin-resistant Staphylococcus aureus by intact cell mass spectrometry,” Journal of Medical Microbiology, vol. 49, no. 3, pp. 295–300, 2000. View at Google Scholar · View at Scopus
  145. J. Walker, A. J. Fox, V. Edwards-Jones, and D. B. Gordon, “Intact cell mass spectrometry (ICMS) used to type methicillin-resistant Staphylococcus aureus: media effects and inter-laboratory reproducibility,” Journal of Microbiological Methods, vol. 48, no. 2-3, pp. 117–126, 2002. View at Publisher · View at Google Scholar · View at Scopus
  146. K. Bernardo, N. Pakulat, M. Macht et al., “Identification and discrimination of Staphylococcus aureus strains using matrix-assisted laser desorption/ionization-time of flight mass spectrometry,” Proteomics, vol. 2, pp. 747–753, 2002. View at Google Scholar
  147. K. A. Jackson, V. Edwards-Jones, C. W. Sutton, and A. J. Fox, “Optimisation of intact cell MALDI method for fingerprinting of methicillin-resistant Staphylococcus aureus,” Journal of Microbiological Methods, vol. 62, no. 3, pp. 273–284, 2005. View at Publisher · View at Google Scholar · View at Scopus
  148. H. N. Shah, L. Rajakaruna, G. Ball et al., “Tracing the transition of methicillin resistance in sub-populations of Staphylococcus aureus, using SELDI-TOF Mass Spectrometry and Artificial Neural Network Analysis,” Systematic and Applied Microbiology, vol. 34, no. 1, pp. 81–86, 2011. View at Publisher · View at Google Scholar · View at Scopus
  149. M. Wolters, H. Rohde, T. Maier et al., “MALDI-TOF MS fingerprinting allows for discrimination of major methicillin-resistant Staphylococcus aureus lineages,” International Journal of Medical Microbiology, vol. 301, no. 1, pp. 64–68, 2011. View at Publisher · View at Google Scholar · View at Scopus
  150. M. Josten, M. Reif, C. Szekat et al., “Analysis of the matrix-assisted laser desorption ionization-time of flight mass spectrum of Staphylococcus aureus identifies mutations that allow differentiation of the main clonal lineages,” Journal of Clinical Microbiology, vol. 51, no. 6, pp. 1809–1817, 2013. View at Publisher · View at Google Scholar · View at Scopus
  151. J.-J. Lu, F.-J. Tsai, C.-M. Ho, Y.-C. Liu, and C.-J. Chen, “Peptide biomarker discovery for identification of methicillin-resistant and vancomycin-intermediate Staphylococcus aureus strains by MALDI-TOF,” Analytical Chemistry, vol. 84, no. 13, pp. 5685–5692, 2012. View at Publisher · View at Google Scholar · View at Scopus
  152. F. Szabados, M. Kaase, A. Anders, and S. G. Gatermann, “Identical MALDI TOF MS-derived peak profiles in a pair of isogenic SCCmec-harboring and SCCmec-lacking strains of Staphylococcus aureus,” The Journal of Infection, vol. 65, no. 5, pp. 400–405, 2012. View at Publisher · View at Google Scholar · View at Scopus
  153. P. A. Majcherczyk, T. McKenna, P. Moreillon, and P. Vaudaux, “The discriminatory power of MALDI-TOF mass spectrometry to differentiate between isogenic teicoplanin-susceptible and teicoplanin-resistant strains of methicillin-resistant Staphylococcus aureus,” FEMS Microbiology Letters, vol. 255, no. 2, pp. 233–239, 2006. View at Publisher · View at Google Scholar · View at Scopus
  154. R. Cantón, M. Akóva, Y. Carmeli et al., “Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe,” Clinical Microbiology and Infection, vol. 18, no. 5, pp. 413–431, 2012. View at Publisher · View at Google Scholar · View at Scopus
  155. N. Woodford, J. F. Turton, and D. M. Livermore, “Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance,” FEMS Microbiology Reviews, vol. 35, no. 5, pp. 736–755, 2011. View at Publisher · View at Google Scholar · View at Scopus
  156. G. C. Conway, S. C. Smole, D. A. Sarracino, R. D. Arbeit, and P. E. Leopold, “Phyloproteomics: species identification of Enterobacteriaceae using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry,” Journal of Molecular Microbiology and Biotechnology, vol. 3, no. 1, pp. 103–112, 2001. View at Google Scholar · View at Scopus
  157. M. Treviño, P. Areses, M. D. Peñalver et al., “Susceptibility trends of Bacteroides fragilis group and characterisation of carbapenemase-producing strains by automated REP-PCR and MALDI TOF,” Anaerobe, vol. 18, no. 1, pp. 37–43, 2012. View at Publisher · View at Google Scholar · View at Scopus
  158. D. S. Perlin, “Resistance to echinocandin-class antifungal drugs,” Drug Resistance Updates, vol. 10, no. 3, pp. 121–130, 2007. View at Publisher · View at Google Scholar · View at Scopus
  159. P. A. Demirev, N. S. Hagan, M. D. Antoine, J. S. Lin, and A. B. Feldman, “Establishing drug resistance in microorganisms by mass spectrometry,” Journal of the American Society for Mass Spectrometry, vol. 24, no. 8, pp. 1194–1201, 2013. View at Publisher · View at Google Scholar · View at Scopus
  160. K. Sparbier, C. Lange, J. Jung, A. Wieser, S. Schubert, and M. Kostrzewa, “Maldi biotyper-based rapid resistance detection by stable-isotope labeling,” Journal of Clinical Microbiology, vol. 51, no. 11, pp. 3741–3748, 2013. View at Publisher · View at Google Scholar · View at Scopus
  161. K. M. Hujer, A. M. Hujer, A. Endimiani et al., “Rapid determination of quinolone resistance in Acinetobacter spp.,” Journal of Clinical Microbiology, vol. 47, no. 5, pp. 1436–1442, 2009. View at Publisher · View at Google Scholar · View at Scopus
  162. C. Massire, C. A. Ivy, R. Lovari et al., “Simultaneous identification of mycobacterial isolates to the species level and determination of tuberculosis drug resistance by PCR followed by electrospray ionization mass spectrometry,” Journal of Clinical Microbiology, vol. 49, no. 3, pp. 908–917, 2011. View at Publisher · View at Google Scholar · View at Scopus
  163. F. Wang, C. Massire, H. Li et al., “Molecular characterization of drug-resistant Mycobacterium tuberculosis isolates circulating in China by multilocus PCR and electrospray ionization mass spectrometry,” Journal of Clinical Microbiology, vol. 49, no. 7, pp. 2719–2721, 2011. View at Publisher · View at Google Scholar · View at Scopus
  164. P. J. Simner, S. P. Buckwalter, J. R. Uhl, and N. L. Wengenack, “Identification of mycobacterium species and Mycobacterium tuberculosis complex resistance determinants by use of Pcrelectrospray ionization mass spectrometry,” Journal of Clinical Microbiology, vol. 51, no. 11, pp. 3492–3498, 2013. View at Publisher · View at Google Scholar · View at Scopus
  165. C. L. Brinkman, P. Vergidis, J. R. Uhl et al., “PCR-electrospray ionization mass spectrometry for direct detection of pathogens and antimicrobial resistance from heart valves in patients with infective endocarditis,” Journal of Clinical Microbiology, vol. 51, no. 7, pp. 2040–2046, 2013. View at Publisher · View at Google Scholar · View at Scopus
  166. D. M. Wolk, L. B. Blyn, T. A. Hall et al., “Pathogen profiling: rapid molecular characterization of Staphylococcus aureus by PCR/electrospray ionization-mass spectrometry and correlation with phenotype,” Journal of Clinical Microbiology, vol. 47, no. 10, pp. 3129–3137, 2009. View at Publisher · View at Google Scholar · View at Scopus
  167. H. C. Yun, R. E. Kreft, M. A. Castillo et al., “Comparison of PCR/electron spray ionization-time-of-flight-mass spectrometry versus traditional clinical microbiology for active surveillance of organisms contaminating high-use surfaces in a burn intensive care unit, an orthopedic ward and healthcare workers,” BMC Infectious Diseases, vol. 12, article 252, 2012. View at Publisher · View at Google Scholar · View at Scopus
  168. W. L. Drew, “Cytomegalovirus resistance testing: pitfalls and problems for the clinician,” Clinical Infectious Diseases, vol. 50, no. 5, pp. 733–736, 2010. View at Publisher · View at Google Scholar · View at Scopus
  169. L. N. Ikryannikova, E. A. Shitikov, D. G. Zhivankova, E. N. Il'ina, M. V. Edelstein, and V. M. Govorun, “A MALDI TOF MS-based minisequencing method for rapid detection of TEM-type extended-spectrum beta-lactamases in clinical strains of Enterobacteriaceae,” Journal of Microbiological Methods, vol. 75, no. 3, pp. 385–391, 2008. View at Publisher · View at Google Scholar · View at Scopus
  170. M. Gniadkowski, “Evolution and epidemiology of extended-spectrum β-lactamases (ESBLs) and ESBL-producing microorganisms,” Clinical Microbiology and Infection, vol. 7, no. 11, pp. 597–608, 2001. View at Publisher · View at Google Scholar · View at Scopus
  171. V. A. Vereshchagin, E. N. Ilina, M. M. Zubkov, T. V. Priputnevich, A. A. Kubanova, and V. M. Govorun, “Detection of fluoroquinolone resistance SNPs in gyrA and parC GENES of Neisseria gonorrhoeae using MALDI-TOF Mass-Spectrometry,” Molekulyarnaya Biologiya, vol. 39, no. 6, pp. 923–932, 2005. View at Google Scholar · View at Scopus
  172. K. T. Momynaliev, O. V. Selezneva, A. A. Kozlova, V. A. Vereshchagin, E. N. Il'ina, and V. M. Govorun, “A2144G is the main mutation in the 235 rRNA gene of Helicobacter pylori associated with clarithromycin resistance,” Genetika, vol. 41, no. 10, pp. 1338–1344, 2005. View at Google Scholar · View at Scopus
  173. L. N. Ikryannikova, M. V. Afanas'ev, T. A. Akopian et al., “Mass-spectrometry based minisequencing method for the rapid detection of drug resistance in Mycobacterium tuberculosis,” Journal of Microbiological Methods, vol. 70, no. 3, pp. 395–405, 2007. View at Publisher · View at Google Scholar · View at Scopus
  174. N. S. Lurain and S. Chou, “Antiviral drug resistance of human cytomegalovirus,” Clinical Microbiology Reviews, vol. 23, no. 4, pp. 689–712, 2010. View at Publisher · View at Google Scholar · View at Scopus
  175. A. Humar and D. Snydman, “Cytomegalovirus in solid organ transplant recipients,” The American Journal of Transplantation, vol. 9, supplement 4, pp. S78–S86, 2009. View at Publisher · View at Google Scholar · View at Scopus
  176. C. N. Kotton, D. Kumar, A. M. Caliendo et al., “International consensus guidelines on the management of cytomegalovirus in solid organ transplantation,” Transplantation, vol. 89, no. 7, pp. 779–795, 2010. View at Publisher · View at Google Scholar · View at Scopus
  177. S. Chou, R. H. Waldemer, A. E. Senters et al., “Cytomegalovirus UL97 phosphotransferase mutations that affect susceptibility to ganciclovir,” Journal of Infectious Diseases, vol. 185, no. 2, pp. 162–169, 2002. View at Publisher · View at Google Scholar · View at Scopus
  178. R. H. Deurenberg and E. E. Stobberingh, “The molecular evolution of hospital- and community-associated methicillin-resistant Staphylococcus aureus,” Current Molecular Medicine, vol. 9, no. 2, pp. 100–115, 2009. View at Publisher · View at Google Scholar · View at Scopus
  179. J. Pootoolal, J. Neu, and G. D. Wright, “Glycopeptide antibiotic resistance,” Annual Review of Pharmacology and Toxicology, vol. 42, pp. 381–408, 2002. View at Publisher · View at Google Scholar · View at Scopus
  180. S. Tschudin-Sutter, R. Frei, M. Dangel, A. Stranden, and A. F. Widmer, “Rate of transmission of extended-spectrum beta-lactamase-producing enterobacteriaceae without contact isolation,” Clinical Infectious Diseases, vol. 55, no. 11, pp. 1505–1511, 2012. View at Publisher · View at Google Scholar · View at Scopus
  181. M. Hilty, B. Y. Betsch, K. Bögli-Stuber et al., “Transmission dynamics of extended-spectrum β-lactamase-producing enterobacteriaceae in the tertiary care hospital and the household setting,” Clinical Infectious Diseases, vol. 55, no. 7, pp. 967–975, 2012. View at Publisher · View at Google Scholar · View at Scopus
  182. J. M. Nerby, R. Gorwitz, L. Lesher et al., “Risk factors for household transmission of community-associated methicillin-resistant staphylococcus aureus,” Pediatric Infectious Disease Journal, vol. 30, no. 11, pp. 927–932, 2011. View at Publisher · View at Google Scholar · View at Scopus
  183. K. Razazi, L. P. G. Derde, M. Verachten, P. Legrand, P. Lesprit, and C. Brun-Buisson, “Clinical impact and risk factors for colonization with extended-spectrum β-lactamaseproducing bacteria in the intensive care unit,” Intensive Care Medicine, vol. 38, no. 11, pp. 1769–1778, 2012. View at Publisher · View at Google Scholar · View at Scopus
  184. X. Didelot, R. Bowden, D. J. Wilson, T. E. A. Peto, and D. W. Crook, “Transforming clinical microbiology with bacterial genome sequencing,” Nature Reviews Genetics, vol. 13, no. 9, pp. 601–612, 2012. View at Publisher · View at Google Scholar · View at Scopus
  185. C. Bertelli and G. Greub, “Rapid bacterial genome sequencing: methods and applications in clinical microbiology,” Clinical Microbiology and Infection, vol. 19, no. 9, pp. 803–813, 2013. View at Publisher · View at Google Scholar · View at Scopus
  186. P. Herindrainy, F. Randrianirina, R. Ratovoson et al., “Rectal carriage of extended-spectrum beta-lactamase-producing Gram-negative bacilli in community settings in Madagascar,” PLoS ONE, vol. 6, no. 7, Article ID e22738, 2011. View at Publisher · View at Google Scholar · View at Scopus
  187. H. Frickmann, A. Hänle, A. Essig et al., “Fluorescence in situ hybridization (FISH) for rapid identification of Salmonella spp. from agar and blood culture broth-An option for the tropics?” International Journal of Medical Microbiology, vol. 303, no. 5, pp. 277–284, 2013. View at Publisher · View at Google Scholar · View at Scopus
  188. A. Kumar, D. Roberts, K. E. Wood et al., “Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock,” Critical Care Medicine, vol. 34, no. 6, pp. 1589–1596, 2006. View at Publisher · View at Google Scholar · View at Scopus
  189. A. Kumar, N. Safdar, S. Kethireddy, and D. Chateau, “A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic/meta-regression study,” Critical Care Medicine, vol. 38, no. 8, pp. 1651–1664, 2010. View at Publisher · View at Google Scholar · View at Scopus